IBIO, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IBIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $99.00K.
- IBIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $31.00K.
- IBIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $77.00K, a 175.00% increase year-over-year.
- IBIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $1.00K, a 66.67% decline year-over-year.
- IBIO, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $130.00K.
- IBIO, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $77.00K, a 42.59% increase from fiscal 2021.
- IBIO, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $54.00K, a 58.46% decline from fiscal 2020.
- IBIO, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $130.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $130.00K 10-K · filed 2026-08-28 | |
| 2025-03-31 | $99.00K 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $31.00K 10-Q · filed 2026-05-12 | |
| 2022-06-30 | $77.00K 10-K · filed 2023-09-27 | |
| 2021-09-30 | $77.00K 10-Q/A · filed 2023-05-19 | |
| 2021-06-30 | $54.00K 10-K · filed 2022-10-11 | |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-12 | |
| 2020-09-30 | $28.00K 10-Q · filed 2022-05-12 | |
| 2020-06-30 | $130.00K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $3.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |